Skip to content

Episode Notes

Source / episode info

  • Episode: 25
  • Title: Divine Intervention Episode 25 – Autonomic Pharmacology Part 3.
  • Published: 2018-04-30
  • Source: Episode page

One-liner

This episode reviews autonomic pharmacology by detailing cholinergic crisis management (organophosphates), diagnosing Myasthenia Gravis with A ChE inhibitors, utilizing muscarinic agonists and antagonists for specific conditions like glaucoma and asthma, and differentiating pharmacological treatments for the three types of urinary incontinence.

High-yield summary

  • Cholinergic Crisis: Caused by excessive acetylcholine (e.g., organophosphates). Treatment involves an anticholinergic agent (atropine) to block muscarinic receptors AND a cholinesterase inhibitor (pridostigmine) to boost A Ch levels and outcompete the toxin.
  • Myasthenia Gravis (MG): Pathophysiology involves autoantibodies against the nicotinic acetylcholine receptor ({A ChR}). Diagnosis is confirmed by detecting anti-{A ChR} antibodies; treatment uses {A ChE} inhibitors (pyridostigmine, neostigmine) to increase synaptic A Ch.
  • Muscarinic Agonists: Used for conditions like dry mouth (Sjögren's syndrome) or angle-closure glaucoma. Examples include pilocarpine and cevilastine.
  • Incontinence Treatment Triad: The treatment depends on the underlying pathophysiology: 1) Urge Incontinence -> Muscarinic Antagonist (e.g., Oxybutynin); 2) Overflow Incontinence -> Muscarinic Agonist (e.g., Bethanechol); 3) Straining/SUI -> Behavioral therapy (Kegel exercises).
  • Vascular Tone: Alpha blockers (Phenoxybenzamine) are used for pheochromocytoma; Beta agonists (Norepinephrine) are preferred over pure alpha agonists in septic shock due to their balanced action.

Learning objectives

  • Differentiate between muscarinic and nicotinic receptor pharmacology and their clinical applications.
  • Recognize the pathophysiology, diagnosis, and management of Myasthenia Gravis and cholinergic poisoning.
  • Apply pharmacological principles to manage different types of urinary incontinence (urge vs. overflow).
  • Understand the sequential blockade required for pheochromocytoma management (\alpha_1 before \beta).
  • Select appropriate muscarinic agonists/antagonists based on specific glandular or organ function deficits (e.g., glaucoma, OAB).

Board exam buzzwords

ConditionKey FindingAssociationBoard Exam Tip
Myasthenia Gravis (MG)Fluctuating muscle weakness; ptosisAutoantibodies against {A ChR} (Nicotinic); treated with A ChE inhibitors.The diagnostic test of choice is checking for anti-{A ChR} antibodies, not just the Tensilon test.
Cholinergic CrisisBradycardia, bronchorrhea, profuse sweating, diarrheaOrganophosphate/Nerve Gas poisoning; excess acetylcholine.Treat with Atropine (Muscarinic blocker) + Pralidostigmine ({A ChE} inhibitor).
Angle-Closure GlaucomaAcute increase in intraocular pressure (IOP); ciliary muscle spasmMuscarinic Agonism; causes pupillary constriction.Use a muscarinic agonist like pilocarpine.
PheochromocytomaParoxysmal hypertension, palpitationsCatecholamine excess ( and receptors).Always block _1 receptors first with an irreversible blocker (Phenoxybenzamine).

Rapid review table

TopicKey PointContextExam Relevance
Cholinergic CrisisAtropine + PralidostigmineOrganophosphate poisoning; excessive A Ch.Remember the two-drug approach: block the effect (Atro) and boost the signal (Prido).
Myasthenia GravisAnti-{A ChR} antibodiesNicotinic receptor blockade at the neuromuscular junction.{A ChE} inhibitors are used to increase synaptic A Ch concentration.
Urinary IncontinenceUrge -> Antagonist; Overflow -> AgonistPathophysiology dictates treatment: blocking excess parasympathetic tone vs. stimulating bladder contraction.This is a classic "matching" question pattern on boards.
Alpha BlockadePhenoxybenzamine (Irreversible)Pheochromocytoma management.Must block alpha receptors first to prevent hypertensive crisis upon blockade.

Board-speak -> diagnosis

Board-speak / Vignette phraseDiagnosis / ConceptWhy it fits
A patient presents with profuse sweating, lacrimation, diarrhea, and bradycardia following pesticide exposure.Cholinergic Crisis (Organophosphate Poisoning)These are classic SLUDGE/DUMBBLE symptoms resulting from excessive cholinergic stimulation due to {A ChE} inhibition.
A 30-year-old woman with dry eyes and mouth is treated with a muscarinic receptor agonist, improving her salivary flow.Sjögren's Syndrome / Muscarinic AgonismThe goal is to stimulate glandular secretion; pilocarpine acts as an agonist on these receptors.
A patient presents with urinary urgency and frequency due to overactive bladder syndrome (OAB).Urge Incontinence -> AntagonismOveractivity suggests excessive parasympathetic tone, which must be blocked using muscarinic antagonists like oxybutynin.
A patient has chronic constipation and is treated with a drug that stimulates colonic motility by increasing acetylcholine levels.Constipation / Muscarinic AgonismThe goal is to stimulate the gut's parasympathetic function; an agonist (like neostigmine) or {A ChE} inhibitor is used.
A patient has chronic urinary retention and requires medication that stimulates bladder contraction by mimicking acetylcholine release.Overflow Incontinence / Muscarinic AgonismThe bladder needs stimulation to empty when the nerves are failing to signal fullness; betanechol is a direct agonist.
A patient with pheochromocytoma is treated initially with an irreversible alpha-blocker before adding beta-blockers.Pheochromocytoma ManagementBlocking _1 receptors first prevents massive catecholamine surge and subsequent unopposed -stimulation (hypertensive crisis). Phenoxybenzamine is the standard choice.

Differential diagnosis / distinguishing features

Cholinergic Overdose Management

Key FeaturesDistinguishing FindingsNext Step
Muscarinic Receptor AntagonistBlocks parasympathetic effects (bronchoconstriction, salivation, GI motility).Use Atropine to counteract excessive muscarinic stimulation.
Cholinesterase InhibitorIncreases synaptic A Ch levels by preventing breakdown.Use Pralidostigmine/Neostigmine to boost A Ch and outcompete the toxin/antagonist.

Management pearls

  • For suspected Myasthenia Gravis, while the Tensilon test (with edrophonium) is historically used, the definitive diagnostic step today is testing for anti-\text{A ChR} antibodies .
  • When treating pheochromocytoma, always start with an \alpha-blocker ( Phenoxybenzamine ) before adding a \beta-blocker to prevent precipitous drops in blood pressure and subsequent unopposed \alpha-stimulation.
  • In angle-closure glaucoma, the goal is pupillary dilation (miosis) via muscarinic agonism; pilocarpine achieves this effect.
  • For acute cholinergic crisis, remember that while atropine blocks muscarinic effects, a cholinesterase inhibitor like pralidoxime/pridostigmine is required to address the underlying excess A Ch.

Don't miss

🚨
The three types of incontinence require distinct pharmacological approaches: Antagonist for Urge, Agonist for Overflow, and behavioral therapy for Straining.
🚨
Phenoxybenzamine is an irreversible \alpha-blocker used in pheochromocytoma; its irreversibility makes it ideal for this emergency setting.
🚨
The mnemonic "Sitting on the Darn Toilet" helps recall muscarinic antagonists for urge incontinence: Solifenacin, Oxybutynin, Terazosin, Doxazosin, Tamsulosin (Note: While tamsulosin is listed here, its primary use in BPH makes it a common trap; focus on the anticholinergic action).

Integration & clinical reasoning

  • Pharmacology & Autonomic Tone: The autonomic nervous system controls nearly every organ system. Understanding receptor types (\alpha, \beta, muscarinic, nicotinic) and their specific agonists/antagonists is crucial for managing crises (e.g., anaphylaxis vs. cholinergic crisis).
  • MG & Nicotinic Receptors: MG specifically targets the nicotinic receptors at the neuromuscular junction, making A ChE inhibitors effective by increasing the concentration of neurotransmitter available to bind these receptors.
  • Vascular Tone & \alpha/\beta Blockade: The management of pheochromocytoma is a prime example of sequential blockade; failure to block \alpha_1 first can lead to life-threatening hypotension or hypertension.

OMM / COMLEX integration

🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
  • Standard emergency management takes priority in acute cholinergic crisis or pheochromocytoma (e.g., immediate airway management and blood pressure control). OMT is adjunctive only after stabilization.
  • The concept of autonomic dysregulation (bladder, vascular tone) relates strongly to viscerosomatic reflexes; understanding the receptor blockade helps predict potential visceral symptoms upon drug administration.

Concept connections / cross-references

  • For detailed coverage on the adrenal medulla and catecholamine excess, review [ Episode 37 ].
  • For general principles of autonomic function and receptor types, see [ Episode 20 ].

High-yield association table

ConditionAssociationMechanismClinical Significance
Myasthenia GravisAnti-{A ChR} antibodiesAutoimmune destruction/blockade of nicotinic receptors.Treatment with {A ChE} inhibitors (e.g., pyridostigmine) to boost synaptic A Ch concentration.
Cholinergic CrisisOrganophosphates / Nerve GasInhibition of Acetylcholinesterase ({A ChE}).Leads to massive accumulation of acetylcholine, causing SLUDGE/DUMBBLE symptoms.
Angle-Closure GlaucomaPilocarpine (Muscarinic Agonist)Stimulates ciliary muscle contraction and pupillary constriction.Used to reduce intraocular pressure by constricting the pupil.
PheochromocytomaPhenoxybenzamine (-blocker)Irreversible blockade of _1 receptors.Must be given first, followed by a -blocker (if needed), to prevent hypertensive crisis.

Key terms glossary

TermDefinitionContextExample
Muscarinic Receptor AgonistDrug that mimics acetylcholine and stimulates muscarinic receptors.Used when glandular secretion or smooth muscle contraction is deficient.Pilocarpine (for glaucoma); Bethanechol (for urinary retention).
Cholinesterase Inhibitor ({A ChE}I)Drug class that prevents the breakdown of acetylcholine in the synaptic cleft.Used to treat MG and cholinergic poisoning.Pyridostigmine, Neostigmine, Pralidoxime.
Cholinergic CrisisOverstimulation of muscarinic receptors due to excessive A Ch.Caused by organophosphates or nerve agents.Symptoms include bronchorrhea, bradycardia, and diarrhea (SLUDGE).
PhenoxybenzamineIrreversible _1 receptor blocker.First-line treatment for pheochromocytoma.Blocks peripheral vasoconstriction to prevent hypertensive crisis.

Study optimization

TopicStudy ApproachPriorityResources
Autonomic PharmacologyCreate flowcharts: Toxin -> Receptor Blockade/Excess -> Treatment Drug Class (Agonist/Antagonist).HighReview drug mechanisms and receptor targets for all major drugs.
Incontinence SyndromesUse a comparison table to match the symptom (Urgency, Overflow, Straining) with the correct pharmacological intervention (Agonist vs Antagonist).Medium-HighFocus on the underlying pathophysiology of each type of incontinence.
Vascular Tone DrugsMemorize the sequence: -blocker first, then -blocker; and recognize irreversible blockers like Phenoxybenzamine.HighPractice vignettes requiring sequential drug administration (e.g., pheochromocytoma).

Question pattern recognition

  • Matching/Differentiating: Matching a specific clinical syndrome (e.g., OAB) to the correct pharmacological class (Antagonist vs Agonist).
  • Sequencing/Order of Operations: Determining the correct order of drug administration in an emergency setting (e.g., pheochromocytoma management).
  • Mechanism of Action: Identifying whether a drug works by blocking, stimulating, or preventing enzyme breakdown.

Test yourself

Common mistakes to avoid

🚫
Mistake 1: Confusing the roles of agonists and antagonists in incontinence. Remember: Urge needs an antagonist (to calm down overactive bladder); Overflow needs an agonist (to stimulate emptying).
🚫
Mistake 2: Assuming all cholinergic symptoms are treated with one drug. Cholinergic crisis requires a two-pronged attack: blocking the effect ( Atropine ) and boosting the signal/outcompeting the toxin ( Pralidostigmine ).
🚫
Mistake 3: Mismanaging pheochromocytoma blockade. Never block \beta-receptors before \alpha-receptors, as this can cause unopposed massive \alpha-stimulation leading to a hypertensive crisis.

Common traps

⚠️
Trap 1 (MG): The Tensilon test is diagnostic but less preferred than antibody testing; the underlying pathology targets nicotinic receptors.
⚠️
Trap 2 (Incontinence): Mistaking the treatment for overflow incontinence (which needs stimulation/agonist) with that of urge incontinence (which needs blockade/antagonist).
⚠️
Trap 3 (Vascular Tone): Assuming \text{Norepinephrine} is sufficient for septic shock; while it's a powerful \alpha_1 agonist, its balanced action makes it superior to pure agonists.

Original transcript with highlights

Original transcript with highlights

Okay, welcome. My name is Divine. I am a 4th theoretical student. Welcome to the 25th episode of the Divine Intervention Podcasts. In today's episode I'm going to finish up Autonomic Pharmacology and hopefully in a future podcast we can begin on a new section of Pharmacology. So let's get going. So last time we sort of rounded out our Ganofosfit poisoning right and we said we talked about how the path of physiology of organophosphate poisoning involves the inhibition of acetylcholinesteries. And if acetylcholinesteries is inhibited, your levels of acetylcholine build up so you get a cholinergic toxidrone. So you get things like a beam hypotensive or a brain-bedded cardiac because remember your parasympathetic nervous system sort of like cardio depresses the heart. So you get pretty cardio because phase 4 of the pacemaker potential is going much slower. That slope is reduced by colinomematics. You could also get like heart block, you could get like profuse sweating because remember your sweat glands are under the control of the sympathetic nervous system but the under that control with oscarinic acetylcholine receptors. So you get more your inesion, you could get fecal incontinence, again remember your rest and digest it, your pooping and pee and frilly. You can also get lacrimation because remember that's under the purview of cranial nerve 7. And cranial nerve 7 is part of your parasympathetic nervous system.

Remember the parasympathetic nervous system is regarded as cranial sacral outflow. So the cranial part includes cranial nerves like 3, 7, so 3 right, your glomoner of 7, the facial nerve 9, the glossopharyngeal nerve and 10, the vagus nerve. And we said that you treat a gonophosphate poisoning with an acetylcholine receptor antagonist like atropine and then you try to regenerate the acetylcholine esteris with pre-conducting. Okay, so the next set of drugs we'll talk about, let's talk about the moscaryne receptor agonists. The moscaryne receptor agonists, I sort of think of them as being in two classes. We have those that directly attack the receptor. So they directly activate the receptor and then we have those that indirectly activate the receptor. And what do I mean by indirect activation? I mean drugs that inhibit acetylcholine esteris and in so doing increase your levels of acetylcholine. And then if you have increased levels of acetylcholine, you can then activate the moscaryne receptors more. Okay, so one example of an, so let's talk about the first group, the acetylcholine esteris inhibitors. The first group I'll talk about is a nerve gas, right? So sorry, sorry, again works by inhibiting acetylcholine esteris so you can get a collineurgic toxicant from that. Same thing with organophosphates, okay, organophosphates, the acetylcholine esteris inhibitors. So those boost your acetylcholine levels. We've talked about how you treat that.

And then if a patient has my astenia gravins, right, because again, I don't just want to give you drug names, right? I want to show you how you'll be tested. For patient has my astenia gravins, right? You'll want to, the pathophysiology there involves having autoantibodies against the acetylcholine receptor. So you want to try to fix that by creating acetylcholine that can outcompete those aberrant autoantibodies, right? So you do that by giving that acetylcholine esteris inhibitor, like pyridolstigmin. So remember that in my astenia gravins, right, usually you'll see, what's your first step in management or diagnosis? And back in the day was, I gave the tensilent test or whatever. They may still describe it as an experiment or whatever on step one. But in general, right now, the diagnostic test of choice is checking for the antiacetylcholine receptor antibodies. So that's the preferred diagnostic test these days. But you can still go with the tensilent test where you had myastage or phonium, which is an acetylcholine esteris inhibitor. It's a very short acting acetylcholine esteris inhibitor, okay? And your levels of acetylcholine are built up and that transiently improves the symptoms in my astenia gravins. Now, new stigmin and pyridolstigmin, I mean, a new stigmin is another acetylcholine esteris inhibitor. Classically, it's used to treat like post-op elias, right? So after you undergo surgery with anesthetics, your GI tract may be locked up for a bit.

You could try to fix that problem by giving something that encourages your GI tract to go like new stigmin. You build up your acetylcholine levels and remember acetylcholine promotes pooping and pee. Because that's part of the, under the purview of the past and pathetic nervous system. Now, if a person has Alzheimer's disease, right, they have reduced levels of what neurotransmitter? They have reduced levels of acetylcholine, okay? So there are certain things you want to know with acetylcholine in relation to Alzheimer's. So one thing you want to know is that first, the region of the brain, where acetylcholine is produced, okay? The occasionally love to test that that region of the brain is destroyed in Alzheimer's disease, right? So the acetylcholine is actually produced at a structure called the bison nucleus of minor. Okay? So destruction of the bison nucleus of minor is associated with an acetylcholine deficiency, if you may, which is associated with the pathophysiology of Alzheimer's. And another more advanced way they can test the same concept is to say that, oh, Alzheimer's is associated with reduced activity of cooling acetylcholine. Remember, cooling acetylcholine is the real limiting enzyme for acetylcholine synthesis. So in Alzheimer's, if you know that you have an acetylcholine deficiency, you want to try to fix that, right? By doing something that boosts your acetylcholine levels. This is again where an acetylcholine esterase inhibitor comes into play, right?

So the drugs that are approved by the FDA for acetylcholine esterase inhibition in the treatment of my acetylcholine esterase inhibition, okay? Include drugs like d'unepezile. The nepezile is an acetylcholine esterase inhibitor. Galantamine is another acetylcholine esterase inhibitor. Rereverstigme is another acetylcholine esterase inhibitor. And then there is one more that's not so common. Tachran is also an acetylcholine esterase inhibitor that's used to treat Alzheimer's. And remember that patients with Down syndrome add increased risk of early Alzheimer's, right? Because they have three copies of that pre-syniline gene on chromosome 21. Okay, so those are the big things you want to know about your acetylcholine esterase inhibitors. Now let's go to the direct-moscrinic receptor agonist, okay? So these include drugs like Bethanychol, Bethanychol is a muscrinic receptor agonist. You're going to need it for post-op areas. Now what if you get a question about a lady, like in her 30s, that has dental caries? And she feels like a lump in her truth. And she says, oh, I have to get up at night multiple times to drink water because my tongue gets dry. Well, hopefully that helps you think about show greens. Remember show greens is associated with anti-ro, or anti-SSAO, anti-la, or anti-SSB antibodies. You can treat show greens to dryness with a pylocarpin. Pylocarpin is a more of scurrenic receptor agonist that can help you make more saliva.

And remember that pylocarpin can also be used in the treatment of acute anguclujoglocoma, okay? Because you want to try to relieve pressure through those canals of schlim. So you can do that by causing pupillary constriction. And you can use a moscurrenic receptor agonist like pylocarpin for that. And just real quick, while we're on the topic of show greens, don't forget that they had increased risk of a non-hotch. And then we're going to talk about non-hotch.in's B-cell lymph. Excuse me, a non-hotch.in's B-cell lymph from the over activation of lymphoid cells in their salivary glands, for example. Now, the last direct moscurrenic agonist I want to talk about is methacolin, okay? Methacolin is a moscurrenic receptor agonist that is using provocative testing for asthma. So, big things you want to know that if you activate your sympathetic nervous system, you open up your earways, okay? And you can sort of think about that teleologically if you may, because think about it. If you're running from a lion, you want as much energy as possible to make that happen, okay? And to get more energy, more ATP in oxidative phosphorylation, you need oxygen. So, if your earways are open up some more, right? You can get in more oxygen. You can promote electron-transport chain and oxidative phosphorylation that you survive, okay? So, activating your sympathetic nervous system opens up your earway, okay? But, activating your parasympathetic nervous system closes your earway.

That is why I'll be it around, which is a bit of a receptor agonist, is using the treatment of asthma. And, hypertropium or tyotropium, which are moscurrenic receptor and antagonists are used in the treatment of asthma, okay? So, if you want to have a provocative test for asthma, you actually give a moscurrenic receptor agonist like metheculin. In general, you use pretty diluted concentrations. And in most people, when you give them those dilute concentrations, they don't get much in the well of bronchospasin with that. But, in a person that has hypersensitive earways, you give them those dilute concentrations of metheculin, you get bronchoconstriction, the person's FIV1 decreases by some percentage, and there are some codos for the diagnosis of asthma, okay? So, you have like a standardized decrease in FIV1, and you're like, oh, this person has asthma, and then you sort of go from there, okay? So, metheculin can be used in provocative tests for asthma. Now, let's talk about the moscurrenic receptor antagonists. We've sort of talked about these already. Astropine, remember, you can use that for heart block, okay? Because by blocking moscurrenic receptors, they will increase the speed of conduction through the AV node. And for atropine, right, if you're exposed to gymsim weed, you could get an antichoninergic toxic drum from atropine, okay? And the way you treat an atropine overdose, remember, atropine is a moscurrenic receptor antagonist, right?

So, again, you want to try to boost your levels of acyloculin to outcompete atropine at the moscurrenic receptor. So, you do that with a drug known as phyzo-stigmin. Phyzo-stigmin is an acyloculinistries inhibitor that boosts your levels of acyloculin to overcom, to have a common atropine overdose. Scopolamine is another moscurrenic receptor antagonist. You're primarily using fomotion sickness. So, too much acyloculin in your vestibular system causes a lot of like vestibular symptoms, motion sickness symptoms, c-signus symptoms. So, you can treat that by blocking acyloculin receptors. That's why you see many people, they take better drugs or diphenhydramine for motion sickness because diphenhydramine has, yes, it's an antichistamine, but it has very powerful moscurrenic receptor blocking activity. And then, apatropium tootropium, they are also moscurrenic receptor antagonists. Use those more for asthma and COPD. Apatropium is a shorter actin moscurrenic antagonist. The etiotropium is longer actin. And the easy way to remember that is I come before t-in the alphabet. So, I come separately. So, it's short actin. T comes later. So, it's long actin. So, let's round out this discussion by talking about the three types of incontinence. They love to really test this in the context of the parasympathetic nervous system. So, the first one we will talk about is urgent incontinence. It's the one called overactive bladder.

This is something you could potentially find on exams in a patient with multiple sclerosis. So, in this case, the tetrothomeal salts are too active. So, they are working too well. So, these people, they can't get to the restroom before they peel themselves. So, because your tetrothomeal salts are working too well, remember your parasympathetic nervous system makes UP. You can try to reverse that pathology by blocking moscurrenic receptors. So, actually moscurrenic receptor antagonists are very good in the treatment of urge incontinence. And there's a nice nomonic you'll learn as you study for step one. It's called sitting on the darn toilet for the moscurrenic receptor antagonists that are classically used in the treatment of urge incontinence. So, we have drugs like sulafenacin, we have oxybutin, that's the O, we have to teradine, we have daryphenacin and then we have trospial. So, sitting on the darn toilet, those are the moscurrenic receptor antagonists that are used for urge incontinence. Now, if you're dealing with overflowing continents, right, so overflowing continents, the tetrothomeal salts are basically not doing anything because the nerves in your bladder, they can detect when the bladder is full for some reason. And again, this is something that may potentially be found in a patient with a history of multiple sclerosis.

So, for this, because your bladder nerves are not detecting anything, so you're holding onto pee, okay, so these people usually like pee in small spurs when the pressures in the bladder are just too much, where they just have to let out some urine. So, you can try to treat that either with like self-catheterization or you can also give a moscurrenic receptor agonist, okay, to encourage pee because again, you're not sensing anything, so you want to encourage pee by giving a moscurrenic receptor agonist like Bethanico, okay, so notice different kinds of incontinence, but different kinds of treatment, okay, so for urge incontinence, you give a moscurrenic receptor antagonist for overflowing continents, you give a moscurrenic receptor agonist. And then the final one, stressing continents, basically, let's assume you're basically erect a lot of your pelvic floor muscles in the context of multiple childbirths, okay, the classic presentation is a patient that has that pee on themselves when they have an increase in intraptominal pressure, so if they laugh or if they perform any kind of valve-solver-ish maneuver, okay, anything that increases intraptominal pressure increases the loss of urine under those quits. So, the way you treat that, you don't necessarily jump to pharmacology, you can use a kegalexercises, okay, and then you can do surgery if kegalexercises.work. So, this is basically where I'm going to stop with autonomic pharmacology, we're pretty much done.

I'll just do a very quick review of some very high-yield things we talked about along the way. So, remember that in phyocromocytomas, right, you want to use, you want to block alpha receptors first before you block beta receptors. And those alpha receptors, you can block them with like phenoxybenzamine, it's an irreversible alpha one receptor blocker, femtolamine is a reversible alpha one receptor blocker. So, be able to think of those in the context of mechalism and kinetics. And then if a patient has like BPH and Comitant hypertension, right, you want to treat that with an alpha one blocker like Prasocin or Doxazocin, remember, Tamsulocin was the one that was selected for the alpha one 80 receptors that you find in the bladder. And then, clonidin, right, to remember it's an alpha two agonist using the treat hypertension. Remember, alpha two receptors are GI coupled, so they decrease the release of neuropinephrine, so you could use it to treat hypertension. But you want to be wary of a side effect, if you stop the drug, the hypertension comes back in like very full force, okay. So, rebound hypertension is a very big side effect of clonidin. You could actually use clonidin to treat the, you could actually use clonidin in the treatment of Tourette's syndrome. It's just one of those bizarre things you want to know for your exam.

And then, proprylonal law, right, so proprylonal law is a beta one and two receptor blocker, remember, it's used in thyroid storm, because when it helps with the hypoallergenic symptoms, but proprylonal law also inhibits the 5-prem DIO-denies that converts T4 to T3. And in thyroid storm, we said in addition to using proprylonal law, right, you can use steroids, okay. You can use PTU, remember, PTU is a thyroid peroxidis inhibitor, but it also inhibits that 5-prime DIO-denies. And then, my Modepine, just throwing this in here, the person has like a hemorrhagic stroke, like after a subarachnoid hemorrhagin, they say, oh, worst headache of your life, or a thonda-clap headache, or headache that is different in character. From previous headaches, you can give my Modepine, it's a dihydropyridine calcium channel blocker that prevents post-tromatic hemorrhagic stroke, so that they don't get an ischemic stroke after a hemorrhagic stroke. And then, if you want to delete the delivery, right, you want to give a beta to Agnes, because remember, beta to receptors, and in smooth muscle, that causes a relaxation, okay. So, if a patient has, you're trying to delete the delivery for some reason, let's say, for like preterm labor, you can give a beta to Agnes, like terbidolino redogin, they are tocoletics, and they can delete the delivery. Now, for an aphylaxis, right, don't forget that your drug of choice is a penephrase, okay.

Because in an aphylaxis, you want to affect beta to receptors to open up earways, okay. And remember, narypinephrine won't do squat for you in an aphylaxis, right, because it does not necessarily activate beta to receptors. But if a person is in septic shock, narypinephrine, great, okay. Because again, it's a powerful alpha-1 receptor agonist, so that helps you in septic shock, because it sort of increases your systemic vascular resistance to counteract the severe visual dilation. And then, do butamine, right, remember, it's a beta-1 agonist, you can use it in a C-HF and acute C-HF exacerbation, okay. You could also use it in a cardiac stress test. We talked about merino, that is a force for diester, it's 3 inhibitor, so it builds up your levels of cyclic AMP. So, we talked about how that helps your cardiac muscle contract better, so it's a positive inotroup, okay. But that causes smooth muscle relaxation, okay. So, it's also a visual dileter, right. So, it's an I-Nodeileter, if you may. And then, we talked about pylocarpine in the context of synthesis of saliva for chagrin, and also for the treatment of acute anglochlojure, glaucoma. And then, we talked about fixing an atropine overdose with phyzo-stigmin, okay. That's an acetylcholine esterase inhibitor. And then, echothio-fate, it's an acetylcholine esterase inhibitor, it's just one of those weird drugs that just sort of put that in your memory bank.

As another acetylcholine esterase inhibitor, we talked about adrofolio, used it in the tensileant test for the diagnosis of myastiniaegraphis. And then, homotropine cyclopentolytentropicamide, these are all actually most chronic receptor antagonists that I use for diluted eye exams, try because remember, if you activate your parasympathetic system, you get meiosis. So, if you block it, you get my dry asses. Back in the day, people used to use atropine, but atropine sort of ticks forever to wash out of your system. So, the inventive, these are short acting drugs, okay. Homotropine, sort of sounds like atropine, right. Atropicamides and glopentolytia, all short acting, most chronic receptor antagonists. And then, middle drain is a visoactive agent, it causes viso-construction. It turns this up your blood vessels, okay. It's actually used for the treatment of dysautonomia, okay. Where a person has like very libel, I guess, on stable blood pressures based on changes in position. So, I think that's where I'm going to stop. Next time, we'll pick up with another branch of pharmacology or a different subject, but we'll keep matching through pharmacologists, we go along in the coming weeks. So, have a wonderful day and stay blessed. Thank you.

Practice questions — USMLE style

Question 1 — Toxicology

A 35-year-old construction worker is exposed to a nerve agent in an industrial accident. Upon presentation, he exhibits profuse sweating, lacrimation, diarrhea, bradycardia, and generalized muscle weakness. Laboratory findings confirm elevated levels of acetylcholine due to inhibition of acetylcholinesterase. The immediate management plan should prioritize which combination of drugs?

  • A) Phenoxybenzamine followed by propranolol
  • B) Atropine sulfate and a cholinesterase reactivator (e.g., pralidoxime)
  • C) Diphenhydramine and pyridostigmine
  • D) Clonidine and physostigmine

Answer: B. The patient is experiencing a cholinergic crisis due to organophosphate poisoning, which inhibits acetylcholinesterase, leading to excessive acetylcholine buildup. Atropine acts as an anticholinergic agent, blocking the muscarinic receptors (M1-M5), thereby mitigating life-threatening symptoms like bradycardia and bronchospasm. A cholinesterase reactivator (oxime) is necessary to regenerate the enzyme that breaks down the excess acetylcholine, reversing the poisoning mechanism. Option B correctly addresses both receptor blockade and enzyme inhibition.

Question 2 — Neurology/Pharmacology

A 70-year-old woman presents with progressive muscle weakness and ptosis, symptoms consistent with myasthenia gravis (MG). She also has a history of generalized cognitive decline. The physician suspects that the underlying pathophysiology involves impaired neurotransmitter signaling at the neuromuscular junction and in the central nervous system. Which class of drugs is most appropriate for managing both conditions by increasing synaptic acetylcholine levels?

  • A) Muscarinic receptor antagonists, such as atropine
  • B) Alpha-1 adrenergic agonists, such as phenylephrine
  • C) Acetylcholinesterase inhibitors, such as pyridostigmine or donepezil
  • D) Beta-2 selective agonists, such as albuterol

Answer: C. Both myasthenia gravis and Alzheimer's disease involve impaired cholinergic signaling. In MG, the goal is to boost acetylcholine (A Ch) levels at the neuromuscular junction by inhibiting acetylcholinesterase (A ChE). Similarly, in Alzheimer's disease, A ChE inhibitors (e.g., donepezil) are used to increase synaptic A Ch levels. These drugs work by preventing the breakdown of A Ch, allowing it to outcompete autoantibodies (in MG) or improve cognitive function (in AD).

Question 3 — Urology/Pharmacology

A 68-year-old man with a history of chronic urinary retention presents with episodes of small, frequent leaks of urine throughout the day, especially when he is resting. Physical examination reveals no signs of obstruction. The physician suspects an overactive bladder (OAB) syndrome. Which pharmacological class and mechanism would be most appropriate for treating this condition?

  • A) Muscarinic receptor agonist; to stimulate detrusor muscle contraction
  • B) Alpha-1 adrenergic antagonist; to relax the smooth muscle of the prostate
  • C) Muscarinic receptor antagonist; to decrease involuntary bladder contractions
  • D) Beta-3 agonist; to increase urethral sphincter tone

Answer: C. The patient is presenting with symptoms consistent with OAB, which involves involuntary detrusor overactivity (excessive parasympathetic signaling). Muscarinic receptor antagonists (e.g., oxybutynin, doxepin) block the action of acetylcholine on the bladder wall, thereby relaxing the detrusor muscle and decreasing the frequency and urgency of urination. Option C correctly identifies the target receptors and the therapeutic goal for OAB.

Question 4 — Endocrinology/Pharmacology

A patient is diagnosed with a pheochromocytoma, presenting with paroxysmal episodes of severe hypertension. The initial pharmacological management must address the excessive catecholamine release in a specific sequence to prevent life-threatening complications. What is the correct initial blockade strategy?

  • A) Block Beta receptors first using propranolol, followed by Alpha-1 blockers
  • B) Block Alpha receptors first using phenoxybenzamine, followed by Beta blockers
  • C) Administer an A ChE inhibitor (e.g., pyridostigmine) to stabilize blood pressure
  • D) Use a direct muscarinic agonist (e.g., pilocarpine) to counteract vasoconstriction

Answer: B. Pheochromocytoma causes excessive release of norepinephrine and epinephrine, leading to severe hypertension primarily through alpha-1 receptor stimulation (vasoconstriction). The initial management must therefore involve blocking the alpha receptors first using an agent like phenoxybenzamine (an irreversible $\alpha_1$ blocker). Blocking alpha receptors prevents massive peripheral vasoconstriction. Once this is achieved, beta blockers can be safely added later to manage tachycardia and prevent excessive sympathetic outflow.

Quick fire review

What is the primary mechanism of action for drugs used to treat Myasthenia Gravis?

They are acetylcholinesterase inhibitors (e.g., Pyridostigmine), which increase acetylcholine levels at the neuromuscular junction.

Which drug class should be given first when managing a patient with pheochromocytoma?

Alpha-1 receptor blockers (e.g., Phenoxybenzamine). This prevents uncontrolled hypertension before blocking beta receptors.

What is the mnemonic used to remember muscarinic antagonists for urge incontinence?

"Sitting on the darn toilet" (Solifenacin, Oxybutynin, Tolteradine, Doxepin/Diphenhydramine, Tiotropium).

Which neurotransmitter deficiency characterizes Alzheimer's disease?

Acetylcholine. The synthesis is impaired in the nucleus basalis of Meynert.

What drug is used to treat a patient with acute angle-closure glaucoma by causing pupillary constriction?

Pilocarpine (a muscarinic receptor agonist).

If a patient has overflow incontinence, what type of pharmacological agent should be administered?

A muscarinic receptor agonist (e.g., Bethanechol), to encourage bladder emptying since the nerves are failing to sense fullness.

What is the diagnostic test of choice for Myasthenia Gravis today?

Checking for anti-acetylcholine receptor antibodies.

Which drug class treats both MG and Alzheimer's disease by boosting acetylcholine levels?

Acetylcholinesterase inhibitors (e.g., Donepezil, Rivastigmine).

What is the key difference in treatment between urge incontinence and overflow incontinence?

Urge requires a muscarinic antagonist (to relax detrusor); Overflow requires a muscarinic agonist (to encourage voiding).

Which drug prevents post-stroke hemorrhagic stroke by blocking calcium channels?

Midodrine.

What is the primary side effect and risk associated with using clonidine for hypertension?

Rebound hypertension upon cessation of the drug.

Name two drugs used as muscarinic receptor antagonists for asthma/COPD, noting their duration of action.

Ipratropium (short-acting) and Tiotropium (long-acting).

What is the specific role of a beta-2 agonist in an anaphylaxis emergency?

To cause bronchodilation by relaxing smooth muscle in the airways, improving oxygenation.

Quick recall / Anki-style questions

What is the diagnostic test of choice for Myasthenia Gravis today?

Checking for anti-acetylcholine receptor antibodies.

Which drug class treats both MG and Alzheimer's disease by boosting acetylcholine levels?

Acetylcholinesterase inhibitors (e.g., Donepezil, Rivastigmine).

What is the key difference in treatment between urge incontinence and overflow incontinence?

Urge requires a muscarinic antagonist (to relax detrusor); Overflow requires a muscarinic agonist (to encourage voiding).

Which drug prevents post-stroke hemorrhagic stroke by blocking calcium channels?

Midodrine.

What is the primary side effect and risk associated with using clonidine for hypertension?

Rebound hypertension upon cessation of the drug.

Name two drugs used as muscarinic receptor antagonists for asthma/COPD, noting their duration of action.

Ipratropium (short-acting) and Tiotropium (long-acting).

What is the specific role of a beta-2 agonist in an anaphylaxis emergency?

To cause bronchodilation by relaxing smooth muscle in the airways, improving oxygenation.